Shanghai, China Yijing Capital is the famous VC, which was founded in 2015. The company was established in Asia in China. The leading representative office of defined VC is situated in the Shanghai.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Software, Consulting. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Shanutec, iyiou.com, Yidebang. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Yijing Capital, startups are often financed by Qiaojing Capital, Gaorong Capital, Xiamen Changrong Investment Management. The meaningful sponsors for the fund in investment in the same round are Xiamen Changrong Investment Management, StarVC, Sinovation Ventures. In the next rounds fund is usually obtained by Xiamen Changrong Investment Management, StarVC.
Related Funds
Funds with similar focus
| Fund Name | Location |
| BDT Capital Partners | Chicago, Illinois, United States |
| Century Securities | China, Guangdong, Shenzhen |
| Chingona Ventures | Chicago, Illinois, United States |
| EOS Global | China, Hong Kong, Hong Kong Island |
| Front Street Capital | Canada, Ontario, Toronto |
| Gate.io | Illinois, Malta, United States |
| Jieliyuan Group | - |
| Newport Private Wealth | Canada, Ontario, Toronto |
| Prime Holdings | - |
| Rio Ventures | - |
| SkyKnight Capital | California, San Francisco, United States |
| Stock Exchange Executive Council of China | Beijing, Beijing, China |
| Sypress | - |
| Technologies Investment | New York, New York, United States |
| The J&J Group | - |
| The Pink Ceiling | North Carolina, Raleigh, United States |
| Vision Blue Solutions | County Dublin, Dublin, Ireland |
| Yaskawa Electric | China, Huangpu, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vertaxi | $30M | 19 Sep 2024 | Zhuhai, Guangdong, China | ||
Phomera | $15M | 29 Apr 2024 | Zhuhai, Guangdong, China | ||
Arnatar Therapeutics | $50M | 08 Apr 2024 | San Diego, California, United States | ||
Kangpu Bio-Pharma | $15M | 30 Aug 2023 | Shanghai, China | ||
Taichu Biotechnology | 08 May 2023 | Shanghai, Shanghai, China | |||
Tasogare | 01 Aug 2022 | Hangzhou, Zhejiang, China | |||
Zhongguancun Shuimu Medical | $15M | 22 Jul 2022 | Beijing, Beijing, China | ||
CytoNiche | $46M | 03 Mar 2022 | Dongcheng District, Beijing, China | ||
InnoStar Semiconductor | 04 Jan 2022 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vertaxi | $30M | 19 Sep 2024 | Zhuhai, Guangdong, China | ||
Phomera | $15M | 29 Apr 2024 | Zhuhai, Guangdong, China | ||
Arnatar Therapeutics | $50M | 08 Apr 2024 | San Diego, California, United States | ||
Kangpu Bio-Pharma | $15M | 30 Aug 2023 | Shanghai, China | ||
Taichu Biotechnology | 08 May 2023 | Shanghai, Shanghai, China | |||
Tasogare | 01 Aug 2022 | Hangzhou, Zhejiang, China | |||
Zhongguancun Shuimu Medical | $15M | 22 Jul 2022 | Beijing, Beijing, China | ||
CytoNiche | $46M | 03 Mar 2022 | Dongcheng District, Beijing, China | ||
InnoStar Semiconductor | 04 Jan 2022 | Shanghai, China |
